Sinopharm : CLOSURE OF THE REGISTER OF MEMBERS

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(A joint stock limited company incorporated in the People's Republic of China with limited liability

and carrying on business in Hong Kong as 國控股份有限公司 )

(Stock Code: 01099)

CLOSURE OF THE REGISTER OF MEMBERS

The board of directors (the "Board") of Sinopharm Group Co. Ltd. (the "Company") hereby announces that whereas the term of office of the fourth session of the Board of the Company and the fourth session of the supervisory committee (the "Supervisory Committee") of the Company will expire on 20 September 2020, the Company proposed to convene and hold an extraordinary general meeting on Friday, 18 September 2020 to, among others, re-elect and appoint directors of the fifth session of the Board and the shareholder representative supervisor and independent supervisors of the fifth session of the Supervisory Committee. The Company is implementing the internal nomination procedure in relation to the candidates for directors of the fifth session of the Board and supervisors of the fifth session of the Supervisory Committee, and will publish announcement promptly upon the approval of nomination by the Board and Supervisory Committee of the Company, respectively. A circular in relation to, among others, the proposed re-election and appointment of directors and supervisors, together with notice of the extraordinary general meeting is expected to be dispatched to the shareholders of the Company on or before 3 September 2020.

For the purpose of holding the extraordinary general meeting, the register of members of the Company (the "Register") will be closed from Wednesday, 19 August 2020 to Friday, 18 September 2020 (both days inclusive) during which period no transfer of shares of the Company will be registered.

In order to be qualified to attend and vote at the extraordinary general meeting, for holders of H shares of the Company, all transfer documents accompanied by the relevant share certificates must be lodged with the H share registrar of the Company, Computershare Hong Kong Investor Services Limited at Room 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong, no later

1

than 4:30 p.m. on Tuesday, 18 August 2020.

The Shareholders whose names appear on the Register on Wednesday, 19 August 2020 are entitled to attend and vote at the extraordinary general meeting.

By order of the Board

Sinopharm Group Co. Ltd.

Li Zhiming

Chairman

Shanghai, the PRC

4 August 2020

As at the date of this announcement, the executive Directors of the Company are Mr. Li Zhiming, Mr. Yu Qingming and Mr. Liu Yong; the non-executive Directors of the Company are Mr. Chen Qiyu, Mr. Ma Ping, Mr. Hu Jianwei, Mr. Deng Jindong, Mr. Wen Deyong, Ms. Guan Xiaohui and Ms. Feng Rongli; and the independent non-executive Directors of the Company are Mr. Yu Tze Shan Hailson, Mr. Tan Wee Seng, Mr. Liu Zhengdong, Mr. Zhuo Fumin and Mr. Chen Fangruo.

• The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name "Sinopharm Group Co. Ltd.".

2